IL157546A0 - Compounds useful as intermediates for 4-aminoquinoline derivatives - Google Patents
Compounds useful as intermediates for 4-aminoquinoline derivativesInfo
- Publication number
- IL157546A0 IL157546A0 IL15754602A IL15754602A IL157546A0 IL 157546 A0 IL157546 A0 IL 157546A0 IL 15754602 A IL15754602 A IL 15754602A IL 15754602 A IL15754602 A IL 15754602A IL 157546 A0 IL157546 A0 IL 157546A0
- Authority
- IL
- Israel
- Prior art keywords
- intermediates
- compounds useful
- aminoquinoline derivatives
- aminoquinoline
- derivatives
- Prior art date
Links
- 150000005011 4-aminoquinolines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28752201P | 2001-04-30 | 2001-04-30 | |
| PCT/IB2002/001217 WO2002088069A2 (en) | 2001-04-30 | 2002-04-08 | Compounds useful as intermediates for 4-aminoquinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL157546A0 true IL157546A0 (en) | 2004-03-28 |
Family
ID=23103272
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15754602A IL157546A0 (en) | 2001-04-30 | 2002-04-08 | Compounds useful as intermediates for 4-aminoquinoline derivatives |
| IL15754402A IL157544A0 (en) | 2001-04-30 | 2002-04-08 | Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15754402A IL157544A0 (en) | 2001-04-30 | 2002-04-08 | Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6689897B2 (zh) |
| EP (2) | EP1383734B1 (zh) |
| JP (2) | JP3924251B2 (zh) |
| KR (2) | KR100591998B1 (zh) |
| CN (3) | CN100357265C (zh) |
| AR (3) | AR036331A1 (zh) |
| AT (2) | ATE321755T1 (zh) |
| AU (1) | AU2002253448B2 (zh) |
| BR (2) | BR0209291A (zh) |
| CA (2) | CA2445693A1 (zh) |
| CZ (2) | CZ20032898A3 (zh) |
| DE (2) | DE60210265T2 (zh) |
| DK (2) | DK1425270T3 (zh) |
| ES (2) | ES2256461T3 (zh) |
| HK (1) | HK1062294A1 (zh) |
| HU (2) | HU225777B1 (zh) |
| IL (2) | IL157546A0 (zh) |
| MX (2) | MXPA03009936A (zh) |
| PL (2) | PL366584A1 (zh) |
| PT (1) | PT1425270E (zh) |
| RU (2) | RU2265010C2 (zh) |
| TW (1) | TWI250974B (zh) |
| WO (2) | WO2002088085A2 (zh) |
| YU (2) | YU84303A (zh) |
| ZA (2) | ZA200306599B (zh) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197786B1 (en) * | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
| US20040002615A1 (en) * | 2002-06-28 | 2004-01-01 | Allen David Robert | Preparation of chiral amino-nitriles |
| JP2006021999A (ja) * | 2002-07-12 | 2006-01-26 | Kaneka Corp | 光学活性β−アミノニトリル化合物およびその対掌体アミド化合物の製造方法 |
| US7504508B2 (en) | 2002-10-04 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
| PL376156A1 (en) * | 2002-10-04 | 2005-12-27 | Millennium Pharmaceuticals, Inc. | Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| US20090181966A1 (en) * | 2002-10-04 | 2009-07-16 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
| ATE407670T1 (de) | 2002-12-20 | 2008-09-15 | Pfizer Prod Inc | Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer |
| US7601842B2 (en) | 2003-02-18 | 2009-10-13 | Takasago International Corporation | Method for producing an optically active tetrahydroquinoline |
| US7223859B2 (en) | 2003-03-17 | 2007-05-29 | Pfizer Inc. | Method for producing (R)-3-[4-(trifluoromethyl) phenylamino]-pentanoic acid amide derivative |
| JPWO2004083166A1 (ja) * | 2003-03-17 | 2006-06-22 | 株式会社カネカ | （ｒ）−３−［４−（トリフルオロメチル）フェニルアミノ］−ペンタン酸アミド誘導体の製造法 |
| BRPI0414822A (pt) | 2003-09-26 | 2006-11-14 | Japan Tobacco Inc | método de inibir a produção de lipoproteìna remanescente |
| ES2332051T3 (es) * | 2003-10-08 | 2010-01-25 | Eli Lilly And Company | Compuestos y procedimientos para tratar dislipidemia. |
| US7390504B2 (en) * | 2003-11-07 | 2008-06-24 | Jj Pharma, Inc. | HDL-boosting combination therapy complexes |
| EP1740547A1 (en) * | 2004-04-07 | 2007-01-10 | Millennium Pharmaceuticals, Inc. | Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| MXPA06014716A (es) * | 2004-06-24 | 2007-03-12 | Lilly Co Eli | Compuestos y metodos para el tratamiento de dislipidemia. |
| DE102004031656A1 (de) * | 2004-06-30 | 2006-01-19 | Merck Patent Gmbh | Tetrahydrochinoline |
| US7700774B2 (en) * | 2004-12-20 | 2010-04-20 | Dr. Reddy's Laboratories Ltd. | Heterocyclic compounds and their pharmaceutical compositions |
| RU2007135224A (ru) | 2005-02-24 | 2009-03-27 | Милленниум Фармасьютикалз, Инк. (Us) | Антагонисты рецептора pgd2 для лечения воспалительных заболеваний |
| BRPI0611838A2 (pt) * | 2005-06-20 | 2012-08-28 | Astrazeneca Ab | processo para a preparação de um composto |
| TW200808731A (en) | 2006-03-30 | 2008-02-16 | Tanabe Seiyaku Co | A process for preparing tetrahydroquinoline derivatives |
| DE102006031149A1 (de) * | 2006-07-04 | 2008-01-10 | Merck Patent Gmbh | Fluortenside |
| DE102006031151A1 (de) * | 2006-07-04 | 2008-01-10 | Merck Patent Gmbh | Fluortenside |
| DE102006031143A1 (de) * | 2006-07-04 | 2008-01-24 | Merck Patent Gmbh | Fluortenside |
| DE102006032391A1 (de) * | 2006-07-04 | 2008-01-17 | Merck Patent Gmbh | Fluortenside |
| DE102006031262A1 (de) * | 2006-07-04 | 2008-01-10 | Merck Patent Gmbh | Fluortenside |
| CL2008000684A1 (es) | 2007-03-09 | 2008-08-01 | Indigene Pharmaceuticals Inc | Composicion farmaceutica que comprende metformina r-(+) lipoato y un inhibidor de reductasa hmg-coa; formulacion de dosis unitaria; y uso en el tratamiento de una complicacion diabetica. |
| JP2011256110A (ja) * | 2008-09-30 | 2011-12-22 | Takeda Chem Ind Ltd | ヘキサヒドロピロロキノリンの製造法 |
| TWI450896B (zh) | 2009-06-30 | 2014-09-01 | Lilly Co Eli | 反式－４－〔〔（５ｓ）－５－〔〔〔３，５－雙（三氟甲基）苯基〕甲基〕（２－甲基－２ｈ－四唑－５－基）胺基〕－２，３，４，５－四氫－７，９－二甲基－１ｈ－１－苯并氮呯－１－基〕甲基〕－環己基羧酸 |
| PL2697207T3 (pl) | 2011-04-12 | 2017-08-31 | Chong Kun Dang Pharmaceutical Corp. | Pochodne 3-(2-arylocykloalkenylometylo)oksazolidyn-2-onu jako inhibitory białka transportującego estry cholesterolu (cetp) |
| CN103648495A (zh) * | 2011-07-08 | 2014-03-19 | 诺华股份有限公司 | 在高甘油三酯对象中治疗动脉粥样硬化的方法 |
| PL2943474T3 (pl) | 2013-01-31 | 2017-12-29 | Chong Kun Dang Pharmaceutical Corp. | Związki stanowiące pochodne cycloheksenu podstawionego biarylem lub heterocyklicznym biarylem jako inhibitory cetp |
| WO2015067405A1 (en) * | 2013-11-11 | 2015-05-14 | Lonza Ltd | Method for preparation of cyano compounds of the 13th group with a lewis acid |
| HUE059947T2 (hu) * | 2014-08-12 | 2023-01-28 | Newamsterdam Pharma B V | Eljárás tetrahidrokinolin-származékok elõállításához való szintézis-köztitermékek elõállítására |
| CN105294559B (zh) * | 2015-06-24 | 2017-11-14 | 厦门法茉维特动物药业有限公司 | 一种医药中间体4‑氨基喹啉类化合物的合成方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5035813B2 (ja) | 1998-07-10 | 2012-09-26 | マサチューセッツ インスティテュート オブ テクノロジー | 金属用のリガンドおよびそれらに基づいて改善された金属触媒法 |
| US6197786B1 (en) * | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
| GT199900147A (es) * | 1998-09-17 | 1999-09-06 | 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas. |
-
2002
- 2002-04-08 ES ES02722569T patent/ES2256461T3/es not_active Expired - Lifetime
- 2002-04-08 CA CA002445693A patent/CA2445693A1/en not_active Abandoned
- 2002-04-08 RU RU2003131871/04A patent/RU2265010C2/ru not_active IP Right Cessation
- 2002-04-08 PL PL02366584A patent/PL366584A1/xx not_active Application Discontinuation
- 2002-04-08 WO PCT/IB2002/001214 patent/WO2002088085A2/en active IP Right Grant
- 2002-04-08 BR BR0209291-3A patent/BR0209291A/pt not_active IP Right Cessation
- 2002-04-08 KR KR1020037014135A patent/KR100591998B1/ko not_active IP Right Cessation
- 2002-04-08 PL PL02366700A patent/PL366700A1/xx not_active Application Discontinuation
- 2002-04-08 AU AU2002253448A patent/AU2002253448B2/en not_active Ceased
- 2002-04-08 MX MXPA03009936A patent/MXPA03009936A/es active IP Right Grant
- 2002-04-08 IL IL15754602A patent/IL157546A0/xx unknown
- 2002-04-08 JP JP2002585387A patent/JP3924251B2/ja not_active Expired - Fee Related
- 2002-04-08 HU HU0304041A patent/HU225777B1/hu not_active IP Right Cessation
- 2002-04-08 PT PT02722567T patent/PT1425270E/pt unknown
- 2002-04-08 AT AT02722567T patent/ATE321755T1/de not_active IP Right Cessation
- 2002-04-08 CN CNB2005100529529A patent/CN100357265C/zh not_active Expired - Fee Related
- 2002-04-08 ES ES02722567T patent/ES2259080T3/es not_active Expired - Lifetime
- 2002-04-08 CA CA002445623A patent/CA2445623A1/en not_active Abandoned
- 2002-04-08 RU RU2003131870/04A patent/RU2259355C2/ru not_active IP Right Cessation
- 2002-04-08 AT AT02722569T patent/ATE316957T1/de not_active IP Right Cessation
- 2002-04-08 IL IL15754402A patent/IL157544A0/xx unknown
- 2002-04-08 CN CNB028091442A patent/CN1297541C/zh not_active Expired - Fee Related
- 2002-04-08 EP EP02722569A patent/EP1383734B1/en not_active Expired - Lifetime
- 2002-04-08 DK DK02722567T patent/DK1425270T3/da active
- 2002-04-08 WO PCT/IB2002/001217 patent/WO2002088069A2/en active IP Right Grant
- 2002-04-08 EP EP02722567A patent/EP1425270B1/en not_active Expired - Lifetime
- 2002-04-08 DK DK02722569T patent/DK1383734T3/da active
- 2002-04-08 DE DE60210265T patent/DE60210265T2/de not_active Expired - Fee Related
- 2002-04-08 YU YU84303A patent/YU84303A/sh unknown
- 2002-04-08 DE DE60209004T patent/DE60209004T2/de not_active Expired - Fee Related
- 2002-04-08 MX MXPA03009935A patent/MXPA03009935A/es active IP Right Grant
- 2002-04-08 BR BR0209238-7A patent/BR0209238A/pt not_active IP Right Cessation
- 2002-04-08 HU HU0304039A patent/HUP0304039A3/hu unknown
- 2002-04-08 KR KR1020037014134A patent/KR100639745B1/ko not_active IP Right Cessation
- 2002-04-08 CN CNB028091663A patent/CN1267411C/zh not_active Expired - Fee Related
- 2002-04-08 JP JP2002585373A patent/JP3924250B2/ja not_active Expired - Fee Related
- 2002-04-08 CZ CZ20032898A patent/CZ20032898A3/cs unknown
- 2002-04-08 YU YU84403A patent/YU84403A/sh unknown
- 2002-04-08 CZ CZ20032900A patent/CZ20032900A3/cs unknown
- 2002-04-24 TW TW091108446A patent/TWI250974B/zh not_active IP Right Cessation
- 2002-04-29 AR ARP020101576A patent/AR036331A1/es unknown
- 2002-04-29 AR ARP020101575A patent/AR035963A1/es unknown
- 2002-04-30 US US10/137,314 patent/US6689897B2/en not_active Expired - Fee Related
- 2002-04-30 US US10/136,758 patent/US6600045B2/en not_active Expired - Fee Related
-
2003
- 2003-04-18 US US10/418,821 patent/US6706881B2/en not_active Expired - Fee Related
- 2003-08-25 ZA ZA200306599A patent/ZA200306599B/en unknown
- 2003-08-25 ZA ZA200306600A patent/ZA200306600B/en unknown
-
2004
- 2004-06-15 AR ARP040102071A patent/AR044706A2/es not_active Application Discontinuation
- 2004-07-19 HK HK04105255A patent/HK1062294A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157546A0 (en) | Compounds useful as intermediates for 4-aminoquinoline derivatives | |
| EP1451156A4 (en) | 4-AMINOQUINOLINE COMPOUNDS | |
| GB0111861D0 (en) | Novel compounds | |
| AU2002359165A8 (en) | Novel compounds | |
| GB0120818D0 (en) | Heterocyclic compounds | |
| GB0115588D0 (en) | Novel compounds for use as photoinitiators | |
| GB0102470D0 (en) | Novel compounds | |
| AU2002318571A1 (en) | Novel heterocyclic compound | |
| AU2002257943A1 (en) | Novel compounds for use as photoinitiators | |
| AU2002237948A1 (en) | Intermediate compounds useful for making antiviral compounds | |
| AU2002313179A1 (en) | Processes for preparation of heterocyclic compounds | |
| AU2002251553A1 (en) | Heterocyclic compounds | |
| GB0113803D0 (en) | Novel compounds | |
| GB0100180D0 (en) | Novel compounds | |
| GB0113099D0 (en) | Novel Compounds | |
| GB0113516D0 (en) | Novel Compounds | |
| GB0113802D0 (en) | Novel compounds | |
| GB0112800D0 (en) | Novel compounds | |
| GB0119156D0 (en) | Novel compounds | |
| GB0119355D0 (en) | Novel compounds | |
| GB0119504D0 (en) | Novel compounds | |
| GB0129118D0 (en) | Novel compounds | |
| GB0129134D0 (en) | Novel compounds | |
| GB0102570D0 (en) | Novel Compounds | |
| GB0100037D0 (en) | Novel compounds |